Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Andrews

Showing results (821-830 of 875) with videos related to

Pageof 88
Sort By:
American Journal of Ophthalmology|December 14, 2020
The Michigan Vision-Related Anxiety Questionnaire: A Psychosocial Outcomes Measure for Inherited Retinal DegenerationsGabrielle D Lacy, Maria Fernanda Abalem, Chris A Andrews, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|May 18, 2022
Design of a Randomized, Placebo-Controlled, Phase 3 Trial of Tofersen Initiated in Clinically Presymptomatic SOD1 Variant Carriers: the ATLAS StudyMichael Benatar, Joanne Wuu, Peter M Andersen, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 8, 2010
Genetic immunization in the lung induces potent local and systemic immune responsesKaimei Song, Diane L Bolton, Chih-Jen Wei, et al.
The Journal of Infectious Diseases|November 17, 2006
Phase 1 safety and immunogenicity evaluation of a multiclade HIV-1 candidate vaccine delivered by a replication-defective recombinant adenovirus vectorAndrew T Catanzaro, Richard A Koup, Mario Roederer, et al.
The Journal of Infectious Diseases|January 15, 2008
A West Nile virus DNA vaccine induces neutralizing antibody in healthy adults during a phase 1 clinical trialJulie E Martin, Theodore C Pierson, Sarah Hubka, et al.
Regulatory Toxicology and Pharmacology : RTP|April 1, 1997
Considerations for toxicology studies of respiratory drug productsJ J DeGeorge, C H Ahn, P A Andrews, et al.
Pain|May 11, 2022
Automated preclinical detection of mechanical pain hypersensitivity and analgesiaZihe Zhang, David P Roberson, Masakazu Kotoda, et al.
Clinical & Experimental Ophthalmology|February 27, 2026
Decline of Visual Function and Risk of Legal Blindness With Age in RPGR-Associated Retinal Degeneration: A Multicenter StudyBela J Parekh, Joshua D Stein, Rebhi Abuzaitoun, et al.
AIDS Research and Human Retroviruses|August 4, 2015
IgG Antibody Responses to Recombinant gp120 Proteins, gp70V1/V2 Scaffolds, and a CyclicV2 Peptide in Thai Phase I/II Vaccine Trials Using Different Vaccine RegimensNicos Karasavvas, Chitraporn Karnasuta, Hathairat Savadsuk, et al.
Molecular Genetics & Genomic Medicine|May 27, 2017
SDHA related tumorigenesis: a new case series and literature review for variant interpretation and pathogenicityRuth T Casey, David B Ascher, Eleanor Rattenberry, et al.
Pageof 88

Showing results (821-830 of 875) with videos related to

Sort By:
Pageof 88
American Journal of Ophthalmology|December 14, 2020
The Michigan Vision-Related Anxiety Questionnaire: A Psychosocial Outcomes Measure for Inherited Retinal DegenerationsGabrielle D Lacy, Maria Fernanda Abalem, Chris A Andrews, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|May 18, 2022
Design of a Randomized, Placebo-Controlled, Phase 3 Trial of Tofersen Initiated in Clinically Presymptomatic SOD1 Variant Carriers: the ATLAS StudyMichael Benatar, Joanne Wuu, Peter M Andersen, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 8, 2010
Genetic immunization in the lung induces potent local and systemic immune responsesKaimei Song, Diane L Bolton, Chih-Jen Wei, et al.
The Journal of Infectious Diseases|November 17, 2006
Phase 1 safety and immunogenicity evaluation of a multiclade HIV-1 candidate vaccine delivered by a replication-defective recombinant adenovirus vectorAndrew T Catanzaro, Richard A Koup, Mario Roederer, et al.
The Journal of Infectious Diseases|January 15, 2008
A West Nile virus DNA vaccine induces neutralizing antibody in healthy adults during a phase 1 clinical trialJulie E Martin, Theodore C Pierson, Sarah Hubka, et al.
Regulatory Toxicology and Pharmacology : RTP|April 1, 1997
Considerations for toxicology studies of respiratory drug productsJ J DeGeorge, C H Ahn, P A Andrews, et al.
Pain|May 11, 2022
Automated preclinical detection of mechanical pain hypersensitivity and analgesiaZihe Zhang, David P Roberson, Masakazu Kotoda, et al.
Clinical & Experimental Ophthalmology|February 27, 2026
Decline of Visual Function and Risk of Legal Blindness With Age in RPGR-Associated Retinal Degeneration: A Multicenter StudyBela J Parekh, Joshua D Stein, Rebhi Abuzaitoun, et al.
AIDS Research and Human Retroviruses|August 4, 2015
IgG Antibody Responses to Recombinant gp120 Proteins, gp70V1/V2 Scaffolds, and a CyclicV2 Peptide in Thai Phase I/II Vaccine Trials Using Different Vaccine RegimensNicos Karasavvas, Chitraporn Karnasuta, Hathairat Savadsuk, et al.
Molecular Genetics & Genomic Medicine|May 27, 2017
SDHA related tumorigenesis: a new case series and literature review for variant interpretation and pathogenicityRuth T Casey, David B Ascher, Eleanor Rattenberry, et al.
Pageof 88